Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence

被引：8
作者：
Weerasinghe-Mudiyanselage, Poornima D. E. [1 ,2 ]
Kang, Sohi [1 ,2 ]
Kim, Joong-Sun [1 ,2 ]
Moon, Changjong [1 ,2 ,3 ,4 ]
机构：
[1] Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat & Anim Behav, Gwangju 61186, South Korea
[2] Chonnam Natl Univ, BK21 FOUR Program, Gwangju 61186, South Korea
[3] Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat & Anim Behav, 77 Yongbong Ro, Gwangju 61186, South Korea
[4] Chonnam Natl Univ, BK21 FOUR Program, 77 Yongbong Ro, Gwangju 61186, South Korea
来源：
CURRENT NEUROPHARMACOLOGY | 2023年 / 21卷 / 03期
基金：
新加坡国家研究基金会;
关键词：
Non-motor symptoms; Parkinson's disease; patients' quality of life; preclinical models; therapeutics; rapid eye movement (REM); DEEP BRAIN-STIMULATION; METABOTROPIC GLUTAMATE RECEPTORS; DEPRESSIVE-LIKE BEHAVIOR; MILD COGNITIVE IMPAIRMENT; MONOAMINE-OXIDASE-B; QUALITY-OF-LIFE; ALPHA-SYNUCLEIN; ADENOSINE A(2A); RAT MODEL; MOUSE MODEL;
D O I：
10.2174/1570159X20666221005090126
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Despite being classified as a movement disorder, Parkinson's disease (PD) is characterized by a wide range of non-motor symptoms that significantly affect the patients' quality of life. However, clear evidence-based therapy recommendations for non-motor symptoms of PD are uncommon. Animal models of PD have previously been shown to be useful for advancing the knowledge and treatment of motor symptoms. However, these models may provide insight into and assess therapies for non-motor symptoms in PD. This paper highlights non-motor symptoms in preclinical models of PD and the current position regarding preclinical therapeutic approaches for these non-motor symptoms. This information may be relevant for designing future preclinical investigations of therapies for non-motor symptoms in PD.
引用
收藏
页码：560 / 577
页数：18
相关论文
共 230 条
[31]   Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model [J].
Chatterjee, Diptaman ;
Bhatt, Mansi ;
Butler, David ;
De Genst, Erwin ;
Dobson, Christopher M. ;
Messer, Anne ;
Kordower, Jeffrey H. .
NPJ PARKINSONS DISEASE, 2018, 4
[32]   The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire [J].
Chaudhuri, K. Ray ;
Prieto-Jurcynska, Cristina ;
Naidu, Yogini ;
Mitra, Tanya ;
Frades-Payo, Belen ;
Tluk, Susanne ;
Ruessmann, Anne ;
Odin, Per ;
Macphee, Graeme ;
Stocchi, Fabrizio ;
Ondo, William ;
Sethi, Kapil ;
Schapira, Anthony H. V. ;
Martinez-Martin, Pablo .
MOVEMENT DISORDERS, 2010, 25 (06) :704-709
[33]   Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment [J].
Chaudhuri, K. Ray ;
Schapira, Anthony H. V. .
LANCET NEUROLOGY, 2009, 8 (05) :464-474
[34]   GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice [J].
Chen, Cang ;
Li, Xiuhua ;
Ge, Guo ;
Liu, Jingwei ;
Biju, K. C. ;
Laing, Suzette D. ;
Qian, Yusheng ;
Ballard, Cori ;
He, Zhixu ;
Masliah, Eliezer ;
Clark, Robert A. ;
O'Connor, Jason C. ;
Li, Senlin .
SCIENTIFIC REPORTS, 2018, 8
[35]   Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions [J].
Chen, Li ;
Liu, Jian ;
Ali, Umar ;
Gui, Zhen Hua ;
Hou, Chen ;
Fan, Ling Ling ;
Wang, Yong ;
Wang, Tao .
BRAIN RESEARCH BULLETIN, 2011, 84 (03) :215-223
[36]   SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats [J].
Chen, Lin ;
Deltheil, Thierry ;
Turle-Lorenzo, Nathalie ;
Liberge, Martine ;
Rosier, Corinne ;
Watabe, Isabelle ;
Sreng, Leam ;
Amalric, Marianne ;
Mourre, Christiane .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (08) :1295-1306
[37]   Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease [J].
Chen, Wei ;
Kang, Wen-Yan ;
Chen, Shuai ;
Wang, Ying ;
Xiao, Qin ;
Wang, Gang ;
Liu, Jun ;
Chen, Sheng-Di .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (06) :610-614
[38]   1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease [J].
Chung, Jin Yong ;
Lee, Ji Won ;
Ryu, Choon Ho ;
Min, Hye Kyung ;
Yoon, Yeo Jin ;
Lim, Mi Jung ;
Park, Cheol Hyoung .
JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (08) :1267-1278
[39]   Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease [J].
Church, Frank C. .
BIOMOLECULES, 2021, 11 (04)
[40]   Neuroprotective effects of voluntary running on cognitive dysfunction in an α-synuclein rat model of Parkinson's disease [J].
Crowley, Erin K. ;
Nolan, Yvonne M. ;
Sullivan, Aideen M. .
NEUROBIOLOGY OF AGING, 2018, 65 :60-68
12345678910